Ann Surg

1. BROWN KGM, White K, Solomon MJ, Sutton P, et al
   Life After Pelvic Exenteration for Rectal Cancer: The Patient and Carer Perspective on Long-term Consequences and Survivorship.
   Ann Surg. 2026;283:1082-1087.
   

   >> Share

   
   

   
   Ann Surg Oncol

2. SHIN JK, Kim HC
   ASO Author Reflections: Calibrating Lymph Node Metastasis Risk After Non-curative Endoscopic Resection of pT1 Colorectal Cancer.
   Ann Surg Oncol. 2026 May 12. doi: 10.1245/s10434-026-19747.
   

   >> Share

   
   
3. TANWEER MD, Paz IB, Lwin T, Melstrom L, et al
   Locoregional Control from Complete Peritoneal Cytoreduction in Patients with Extraperitoneal Colorectal Cancer Metastases: An Entropy Balanced Analysis.
   Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19750.
   

   >> Share

   
   
4. NEHME F, Ge PS
   Beyond "High Risk": Toward Individualized Decision-Making After Noncurative Endoscopic Resection of T1 Colorectal Cancer.
   Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19801.
   

   >> Share

   
   

   
   BMC Cancer

5. WANG J, Zhang J, Wu Z, Zhao Y, et al
   Smoking metabolic signature modifies the risk of colorectal cancer and interacts with genetic susceptibility: a large-scale prospective cohort study.
   BMC Cancer. 2026 May 8. doi: 10.1186/s12885-026-16123.
   

   >> Share

   
   
6. WANG L, Yue Q, Li KQ, Fu DH, et al
   Associations of oral health with colorectal cancer risk: accumulated evidences from observational studies.
   BMC Cancer. 2026 May 13. doi: 10.1186/s12885-026-16158.
   

   >> Share

   
   
7. VIRDEE PS, Birks J, Holt T, Snell KIE, et al
   Full BLOOD count TRends for colorectal cAnCer deteCtion (BLOODTRACC): external validation of dynamic clinical prediction models for early detection of colorectal cancer in primary care.
   BMC Cancer. 2026 May 14. doi: 10.1186/s12885-026-16179.
   

   >> Share

   
   

   
   BMC Gastroenterol

8. ABDULLA MM, Salama OE, El-Husseiny G, Ziady HH, et al
   Trends in gastrointestinal cancers at a major tertiary hospital in Alexandria, Egypt: a 10-year retrospective study (2010-2019).
   BMC Gastroenterol. 2026;26:282.
   

   >> Share

   
   

   
   Br J Cancer

9. HASHIMOTO M, Urabe S, Hata T, Chinen Y, et al
   GDF15 promotes 5-Fluorouracil and Oxaliplatin resistance by promoting stem cell-like phenotype in colorectal cancer.
   Br J Cancer. 2026 May 12. doi: 10.1038/s41416-026-03379.
   

   >> Share

   
   

   
   Clin Cancer Res

10. LEE HM, Zheng Z, Sorokin A, Wong CW, et al
    Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer.
    Clin Cancer Res. 2026 May 8. doi: 10.1158/1078-0432.CCR-25-4370.
    

    >> Share

    
    

    
    Eur J Cancer

11. KANHAILAL AC, Knikman JE, Zielhuis SWJ, Kodach LL, et al
    The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.
    Eur J Cancer. 2026;241:116782.
    

    >> Share

    
    

    
    Int J Cancer

12. HOLCH JW, Eisenburger JA, Weber A, Kammermeier-Wehlau I, et al
    The Relevance of Curative-Intent Metastasectomy in Colorectal Cancer Patients: Real-World Insights From a Certified Comprehensive Cancer Center in Germany.
    Int J Cancer. 2026 May 9. doi: 10.1002/ijc.70540.
    

    >> Share

    
    

    
    Int J Colorectal Dis

13. CATANI G, O'Connor JM, Spinelli A, Perea J, et al
    Early-onset colorectal cancer: a comprehensive review reframing hypotheses and defining research priorities.
    Int J Colorectal Dis. 2026 May 11. doi: 10.1007/s00384-026-05145.
    

    >> Share

    
    

    
    J Natl Cancer Inst

14. MADDALENA G, van der Pol Y, Villarreal OE, Coker O, et al
    Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumab.
    J Natl Cancer Inst. 2026;118:903-908.
    

    >> Share

    
    

    
    Lancet

15. KAMINSKI MF, Kalager M, Loberg M, Emilsson L, et al
    Long-term effects of colonoscopy screening on colorectal cancer incidence and mortality: a multicountry, population-based randomised controlled trial.
    Lancet. 2026;407:1787-1795.
    

    >> Share

    
    

    
    Oncogene

16. FENG M, He W, Ji G, Tong L, et al
    Carbohydrate responsive element binding protein promotes colorectal carcinogenesis via Wnt/beta-catenin pathway.
    Oncogene. 2026;45:1890-1900.
    

    >> Share

    
    
17. NIE H, Yu Y, Zhou J, Ning Y, et al
    GBP2 enhances anti-PD-L1 response in colorectal cancer via GSDMD-mediated YAP nuclear translocation by non-pyroptotic.
    Oncogene. 2026 May 11. doi: 10.1038/s41388-026-03816.
    

    >> Share

    
    

    
    PLoS One

18. KUZU AT, Celik N
    First-passage-based boundary estimation in functional data.
    PLoS One. 2026;21:e0348779.
    

    >> Share

    
    
19. CHAROENCHUE P, Rajchakom K, Amantakul A, Pojchamarnwiputh S, et al
    Diagnostic performance of abbreviated non-contrast liver MRI for detecting synchronous colorectal liver metastases.
    PLoS One. 2026;21:e0348972.
    

    >> Share

    
    
20. WANITSUWAN W, Kanjanapradit K, Jearanai S, Suphasynth Y, et al
    WGS identifies Lynch syndrome (LS) patients and uncovers a large family with MSH2-related LS in Southern Thailand.
    PLoS One. 2026;21:e0348867.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share